Studies conducted on patients with obesity and diabetes suggest that retatrutide may be better at zeroing in on fat, preserving more lean muscle mass than earlier generations of injectable GLP-1 drugs like Ozempic and Mounjaro
Its used to treat: Type 2 diabetes (as Ozempic) Obesity or overweight with related health issues (as Wegovy) Its also prescribed off-label by some doctors for weight management in non-diabetics
Lysophosphatidic acid increases proximal tubule cell secretion of profibrotic cytokines PDGF-B and CTGF through LPA2- and galphaq-mediated rho and alphavbeta6 integrin-dependent activation of TGF-beta
Its not worth taking that chance when benefits are unproven, Williams says
If full meals feel impossible, try the protein micro-dose approach, small amounts of protein every 2 to 3 hours
SURMOUNT-1 subgroup data from 2,542 women showed tirzepatide produced ~23% body weight reduction in peri/postmenopausal women vs 3% on placebo